Frequency of pregnant HBV / HCV carriers and status of their internal medicine consultation: A nationwide survey in Japan
Journal of Obstetrics and Gynaecology Research · 2025
DOI: 10.1111/jog.16351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von Manabu Ogoyama und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal and Child Health, Japan Association of Obstetricians and Gynecologists, Tokyo, Japan. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Hepatitis C, Hepatitis B, Internal Medicine. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Infectious Diseases, the Japanese Foundation for Sexual Health Medicine.
Abstract (Originalsprache)
Aim
The present study investigated the prevalence of pregnant hepatitis B (HBV) and hepatitis C (HCV) carriers and their internal medicine consultation rates in Japan.
Methods
A questionnaire was sent to 1931 delivery facilities regarding their delivery management policies and care of pregnant HBV and HCV carriers who delivered between January and December 2023, including internal medicine consultation rates.
Results
Responses were received from 1077 facilities (55.8%). The prevalence of HBV was 0.14% in Japanese women (406/288847) and 3.00% (196/6527) in non‐Japanese women. The prevalence of HBV in 12 Japanese teenagers (≤19 years) was 0.53%, which was significantly higher than that in adult pregnant women (0.14%) ( p < 0.001). HBe antigen was positive in 12.6% of pregnant HBV carriers. The overall prevalence of HCV was 0.23% (684/295374), with similar rates in Japanese and non‐Japanese women (0.23% vs. 0.31%), and 3.1% (21/684) had high HCV‐RNA levels. Internal medicine consultations were performed on 64.8% (295/455) of known HBV carriers before pregnancy and on 66.7% (98/147) of those diagnosed during pregnancy. Regarding HCV, consultation rates were 10.5% (68/645) before pregnancy and 69.2% (27/39) during pregnancy.
Conclusions
The prevalence of pregnant hepatitis virus carriers in Japan is approximately 0.2% for both HBV and HCV, with a high HBV rate in teenagers. Only 60%–70% of patients receive proper internal medicine consultations, highlighting the need for increased awareness among patients, physicians, and healthcare systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Maternal and Child Health, Japan Association of Obstetricians and Gynecologists, Tokyo, Japan.
- Infectious Diseases, Japanese Foundation for Sexual Health Medicine, Tokyo, Japan.
ORCID-Profile: Manabu Ogoyama
Förderung
- Infectious Diseases, the Japanese Foundation for Sexual Health Medicine
Zitieren
APA
Ogoyama, M., Suzuki, S., Hoshi, S. I., Sekizawa, A., Sagara, Y., Ishiwata, I., & Kitamura, T. (2025). Frequency of pregnant HBV / HCV carriers and status of their internal medicine consultation: A nationwide survey in Japan. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16351
Vancouver
Ogoyama M, Suzuki S, Hoshi SI, Sekizawa A, Sagara Y, Ishiwata I, et al. Frequency of pregnant HBV / HCV carriers and status of their internal medicine consultation: A nationwide survey in Japan. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.16351
BibTeX
@article{Ogoyama2025,
author = {Ogoyama, Manabu and Suzuki, Shunji and Hoshi, Shin-Ichi and Sekizawa, Akihiko and Sagara, Yoko and Ishiwata, Isamu and Kitamura, Tadaichi},
title = {Frequency of pregnant HBV / HCV carriers and status of their internal medicine consultation: A nationwide survey in Japan},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
doi = {10.1111/jog.16351}
}
EUVIMED